» Articles » PMID: 36412085

Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database

Abstract

Lung adenocarcinoma (LUAD) is the most common subtype of non-small-cell lung cancer (NSCLC). The aim of our study was to determine prognostic risk factors and establish a novel nomogram for lung adenocarcinoma patients. This retrospective cohort study is based on the Surveillance, Epidemiology, and End Results (SEER) database and the Chinese multicenter lung cancer database. We selected 22,368 eligible LUAD patients diagnosed between 2010 and 2015 from the SEER database and screened them based on the inclusion and exclusion criteria. Subsequently, the patients were randomly divided into the training cohort (n = 15,657) and the testing cohort (n = 6711), with a ratio of 7:3. Meanwhile, 736 eligible LUAD patients from the Chinese multicenter lung cancer database diagnosed between 2011 and 2021 were considered as the validation cohort. We established a nomogram based on each independent prognostic factor analysis for 1-, 3-, and 5-year overall survival (OS) . For the training cohort, the area under the curves (AUCs) for predicting the 1-, 3-, and 5-year OS were 0.806, 0.856, and 0.886. For the testing cohort, AUCs for predicting the 1-, 3-, and 5-year OS were 0.804, 0.849, and 0.873. For the validation cohort, AUCs for predicting the 1-, 3-, and 5-year OS were 0.86, 0.874, and 0.861. The calibration curves were observed to be closer to the ideal 45° dotted line with regard to 1-, 3-, and 5-year OS in the training cohort, the testing cohort, and the validation cohort. The decision curve analysis (DCA) plots indicated that the established nomogram had greater net benefits in comparison with the Tumor-Node-Metastasis (TNM) staging system for predicting 1-, 3-, and 5-year OS of lung adenocarcinoma patients. The Kaplan-Meier curves indicated that patients' survival in the low-risk group was better than that in the high-risk group (< .001). The nomogram performed very well with excellent predictive ability in both the US population and the Chinese population.

Citing Articles

Nomogram predicting overall and cancer specific prognosis for poorly differentiated lung adenocarcinoma after resection based on SEER cohort analysis.

Song W, Shi J, Zhou B, Meng X, Liang M, Gao Y Sci Rep. 2024; 14(1):22045.

PMID: 39333682 PMC: 11436654. DOI: 10.1038/s41598-024-73486-6.


The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery.

Liu Y, Zhang J, Song G, Ding X, Sun H, Zhou J Front Oncol. 2024; 14:1233768.

PMID: 38706605 PMC: 11066224. DOI: 10.3389/fonc.2024.1233768.


Predictors of cancer-specific survival and overall survival among patients aged ≥60 years with lung adenocarcinoma using the SEER database.

Li F, Li F, Zhao D, Lu H J Int Med Res. 2024; 52(4):3000605241240993.

PMID: 38606733 PMC: 11015783. DOI: 10.1177/03000605241240993.


An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study.

Awodutire P, Kattan M, Ilori O, Ilori O Cancers (Basel). 2024; 16(3).

PMID: 38339420 PMC: 10854571. DOI: 10.3390/cancers16030668.


Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery.

Bi S, Jiang Y, Guan G, Sun X, Wang X, Zhang L Ann Surg Oncol. 2024; 31(5):2913-2924.

PMID: 38319516 DOI: 10.1245/s10434-024-14969-8.


References
1.
Li J, Zhu H, Sun L, Xu W, Wang X . Prognostic value of site-specific metastases in lung cancer: A population based study. J Cancer. 2019; 10(14):3079-3086. PMC: 6603375. DOI: 10.7150/jca.30463. View

2.
Xin G, Cao X, Zhao W, Lv P, Qiu G, Li Y . MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma. Math Biosci Eng. 2020; 17(6):8074-8083. DOI: 10.3934/mbe.2020409. View

3.
Chen S, Gao C, Du Q, Tang L, You H, Dong Y . A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study. J Transl Med. 2020; 18(1):436. PMC: 7670679. DOI: 10.1186/s12967-020-02606-3. View

4.
Liao Y, Yin G, Fan X . The Positive Lymph Node Ratio Predicts Survival in TNM Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database. Front Oncol. 2020; 10:1356. PMC: 7438846. DOI: 10.3389/fonc.2020.01356. View

5.
Song C, Guo Z, Shen X, Wang Y, Wang Q, Yu D . Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study. Biomed Res Int. 2020; 2020:7206591. PMC: 7049836. DOI: 10.1155/2020/7206591. View